The requirement of CD8+ T cells to initiate and augment acute cardiac inflammatory response to high blood pressure

Journal of Immunology

Volumn 192, Issue 7, 2014, Pages 3365-3373

  Ma, Feifei ^a   Feng, Jin ^b   Zhang, Chao ^b   Li, Yulin ^c   Qi, Guanming ^a   Li, Huihua ^c   Wu, Yuzhang ^d   Fu, Yangxin ^e   Zhao, Yang ^b   Chen, Hairong ^b   Du, Jie ^a   Tang, Hong ^b,f  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF CHICAGO   (United States)

^f WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; HEART MUSCLE; HYPERTENSION; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANGIOTENSIN II; ANIMALS; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FIBROSIS; FLOW CYTOMETRY; HYPERTENSION; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, 129 STRAIN; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; RECEPTORS, ANTIGEN, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84897548852     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301522     Document Type: Article

References (47)

1. Weber, K. T., C. G. Brilla, and J. S. Janicki. 1993. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc. Res. 27: 341-348.
2. Weber, K. T., and C. G. Brilla. 1991. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849-1865.
3. Brilla, C. G., and K. T. Weber. 1992. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc. Res. 26: 671-677.
4. Marvar, P. J., S. R. Thabet, T. J. Guzik, H. E. Lob, L. A. McCann, C. Weyand, F. J. Gordon, and D. G. Harrison. 2010. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ. Res. 107: 263-270.
5. Porter, K. E., and N. A. Turner. 2009. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 123: 255-278.
6. Frangogiannis, N. G. 2004. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm. Res. 53: 585-595.
7. Bush, E., N. Maeda, W. A. Kuziel, T. C. Dawson, J. N. Wilcox, H. DeLeon, and W. R. Taylor. 2000. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension 36: 360-363.
8. Moriwaki, H., A. Stempien-Otero, M. Kremen, A. E. Cozen, and D. A. Dichek. 2004. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice. Circ. Res. 95: 637-644.
9. Guzik, T. J., N. E. Hoch, K. A. Brown, L. A. McCann, A. Rahman, S. Dikalov, J. Goronzy, C. Weyand, and D. G. Harrison. 2007. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204: 2449-2460.
10. Madhur, M. S., H. E. Lob, L. A. McCann, Y. Iwakura, Y. Blinder, T. J. Guzik, and D. G. Harrison. 2010. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55: 500-507.
11. Barhoumi, T., D. A. Kasal, M. W. Li, L. Shbat, P. Laurant, M. F. Neves, P. Paradis, and E. L. Schiffrin. 2011. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 57: 469-476.
12. Maekawa, Y., N. Mizue, A. Chan, Y. Shi, Y. Liu, S. Dawood, M. Chen, F. Dawood, G. de Couto, G. H. Li, et al. 2009. Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrowderived dendritic cells. Circulation 120: 1401-1414.
13. Higuchi, M. D., M. M. Ries, V. D. Aiello, L. A. Benvenuti, P. S. Gutierrez, G. Bellotti, and F. Pileggi. 1997. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am. J. Trop. Med. Hyg. 56: 485-489.
14. Mönkkönen, J., M. Taskinen, S. O. Auriola, and A. Urtti. 1994. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. J. Drug Target. 2: 299-308.
15. Widder, J. D., T. J. Guzik, C. F. Mueller, R. E. Clempus, H. H. Schmidt, S. I. Dikalov, K. K. Griendling, D. P. Jones, and D. G. Harrison. 2007. Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 27: 762-768.
16. Cheng, J., and J. Du. 2007. Mechanical stretch simulates proliferation of venous smooth muscle cells through activation of the insulin-like growth factor-1 receptor. Arterioscler. Thromb. Vasc. Biol. 27: 1744-1751.
17. Kim, K. D., J. Zhao, S. Auh, X. Yang, P. Du, H. Tang, and Y. X. Fu. 2007. Adaptive immune cells temper initial innate responses. Nat. Med. 13: 1248-1252.
18. Zheng, D., G. Chen, B. Guo, G. Cheng, and H. Tang. 2008. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res. 18: 1105-1113.
19. Li, Y., R. F. Schwabe, T. DeVries-Seimon, P. M. Yao, M. C. Gerbod-Giannone, A. R. Tall, R. J. Davis, R. Flavell, D. A. Brenner, and I. Tabas. 2005. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factoralpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280: 21763-21772.
20. Haudek, S. B., J. Cheng, J. Du, Y. Wang, J. Hermosillo-Rodriguez, J. Trial, G. E. Taffet, and M. L. Entman. 2010. Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 49: 499-507.
21. Savoia, C., D. Burger, N. Nishigaki, A. Montezano, and R. M. Touyz. 2011. Angiotensin II and the vascular phenotype in hypertension. Expert Rev. Mol. Med. 13: e11.
22. Ma, F., Y. Li, L. Jia, Y. Han, J. Cheng, H. Li, Y. Qi, and J. Du. 2012. Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF β/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS ONE 7: e35144.
23. Frangogiannis, N. G., O. Dewald, Y. Xia, G. Ren, S. Haudek, T. Leucker, D. Kraemer, G. Taffet, B. J. Rollins, and M. L. Entman. 2007. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 115: 584-592.
24. Yoshimura, T., E. A. Robinson, S. Tanaka, E. Appella, and E. J. Leonard. 1989. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J. Immunol. 142: 1956-1962.
25. Zhao, J., X. Yang, S. L. Auh, K. D. Kim, H. Tang, and Y. X. Fu. 2009. Do adaptive immune cells suppress or activate innate immunity? Trends Immunol. 30: 8-12.
26. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
27. Zhao, M. Q., M. H. Stoler, A. N. Liu, B. Wei, C. Soguero, Y. S. Hahn, and R. I. Enelow. 2000. Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition. J. Clin. Invest. 106: R49-R58.
28. Small, B. A., S. A. Dressel, C. W. Lawrence, D. R. Drake, III, M. H. Stoler, R. I. Enelow, and T. J. Braciale. 2001. CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells. J. Exp. Med. 194: 1835-1846.
29. Schiffrin, E. L. 2010. T lymphocytes: a role in hypertension? Curr. Opin. Nephrol. Hypertens. 19: 181-186.
30. Harrison, D. G., A. Vinh, H. Lob, and M. S. Madhur. 2010. Role of the adaptive immune system in hypertension. Curr. Opin. Pharmacol. 10: 203-207.
31. Tedgui, A., and Z. Mallat. 2004. Hypertension: a novel regulator of adaptive immunity in atherosclerosis? Hypertension 44: 257-258.
32. Verlohren, S., D. N. Muller, F. C. Luft, and R. Dechend. 2009. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension 54: 439-443.
33. Fernandez-Castelo, S., E. S. Arzt, A. Pesce, M. E. Criscuolo, A. Diaz, S. Finkielman, and V. E. Nahmod. 1987. Angiotensin II regulates interferongamma production. J. Interferon Res. 7: 261-268.
34. Shao, J., M. Nangaku, T. Miyata, R. Inagi, K. Yamada, K. Kurokawa, and T. Fujita. 2003. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 42: 31-38.
35. Thomas, L. 2011. Managing hypertensive emergencies in the ED. Can. Fam. Physician 57: 1137-1197.
36. Rodríguez-Iturbe, B., H. Pons, J. Herrera-Acosta, and R. J. Johnson. 2001. Role of immunocompetent cells in nonimmune renal diseases. Kidney Int. 59: 1626-1640.
37. Qi, G., L. Jia, Y. Li, Y. Bian, J. Cheng, H. Li, C. Xiao, and J. Du. 2011. Angiotensin II infusion-induced inflammation, monocytic fibroblast precursor infiltration, and cardiac fibrosis are pressure dependent. Cardiovasc. Toxicol. 11: 157-167.
38. Markó, L., H. Kvakan, J. K. Park, F. Qadri, B. Spallek, K. J. Binger, E. P. Bowman, M. Kleinewietfeld, V. Fokuhl, R. Dechend, and D. N. Müller. 2012. interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension 60: 1430-1436.
39. Han, Y. L., Y. L. Li, L. X. Jia, J. Z. Cheng, Y. F. Qi, H. J. Zhang, and J. Du. 2012. Reciprocal interaction between macrophages and T cells stimulates IFN-γ and MCP-1 production in Ang II-induced cardiac inflammation and fibrosis. PLoS ONE 7: e35506.
40. Whitmire, J. K., J. T. Tan, and J. L. Whitton. 2005. Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection. J. Exp. Med. 201: 1053-1059.
41. Burman, A. C., T. Banovic, R. D. Kuns, A. D. Clouston, A. C. Stanley, E. S. Morris, V. Rowe, H. Bofinger, R. Skoczylas, N. Raffelt, et al. 2007. IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood 110: 1064-1072.
42. Choi, J., E. D. Ziga, J. Ritchey, L. Collins, J. L. Prior, M. L. Cooper, D. Piwnica-Worms, and J. F. DiPersio. 2012. IFNγR signaling mediates alloreactive T-cell trafficking and GVHD. Blood 120: 4093-4103.
43. Palm, N. W., and R. Medzhitov. 2007. Not so fast: adaptive suppression of innate immunity. Nat. Med. 13: 1142-1144.
44. Tang, H., and Y. Fu. 2010. A new role for T cells in dampening innate inflammatory responses. Sci. China Life Sci. 53: 190-194.
45. Shanker, A. 2010. Adaptive control of innate immunity. Immunol. Lett. 131: 107-112.
46. Nishimura, S., I. Manabe, M. Nagasaki, K. Eto, H. Yamashita, M. Ohsugi, M. Otsu, K. Hara, K. Ueki, S. Sugiura, et al. 2009. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15: 914-920.
47. Winer, S., Y. Chan, G. Paltser, D. Truong, H. Tsui, J. Bahrami, R. Dorfman, Y. Wang, J. Zielenski, F. Mastronardi, et al. 2009. Normalization of obesityassociated insulin resistance through immunotherapy. Nat. Med. 15: 921-929.